Nintx
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $11M
Investors
- 4
About Nintx
Based in Brazil, and founded in 2021 by Miller Freitas, Stephani Saverio, and Cristiano Guimarães Nintx operates as a biotechnology company, that provides novel therapies from complex biological interactions (plants and microorganisms). Nintx believes plant-based natural products have potential to serve as a platform for simultaneously modulating human biological targets and the microbiome, thereby providing therapies for multifactorial diseases (multi-target therapies).
Who invested in Nintx
4 investors across 2 rounds
See all investors in Nintx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nintx
Who invested in Nintx?
Nintx has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nintx raised?
Nintx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nintx last raise money?
Nintx's most recent round on record is a Series A, in Dec 2024.
What does Nintx do?
Based in Brazil, and founded in 2021 by Miller Freitas, Stephani Saverio, and Cristiano Guimarães Nintx operates as a biotechnology company, that provides novel therapies from complex biological interactions (plants and microorganisms).
Where is Nintx headquartered?
Nintx is headquartered in Sao Paulo, Brazil.
Which VCs invest in companies like Nintx?
Among active investors with capital left to deploy, Crescera Capital, Kaszek Ventures, dao5 and LIV Capital back biotechnology companies at Nintx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nintx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.